IL145802A0 - Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol - Google Patents
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcoholInfo
- Publication number
- IL145802A0 IL145802A0 IL14580200A IL14580200A IL145802A0 IL 145802 A0 IL145802 A0 IL 145802A0 IL 14580200 A IL14580200 A IL 14580200A IL 14580200 A IL14580200 A IL 14580200A IL 145802 A0 IL145802 A0 IL 145802A0
- Authority
- IL
- Israel
- Prior art keywords
- heroin
- alcohol
- naltrexone
- reducing consumption
- microsphere compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12847799P | 1999-04-09 | 1999-04-09 | |
PCT/US2000/009438 WO2000061147A1 (en) | 1999-04-09 | 2000-04-08 | Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145802A0 true IL145802A0 (en) | 2002-07-25 |
Family
ID=22435553
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14580200A IL145802A0 (en) | 1999-04-09 | 2000-04-08 | Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
IL145802A IL145802A (en) | 1999-04-09 | 2001-10-05 | Injectable compounds of naltrexone microspheres and their uses in lowering heroin and alcohol consumption |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL145802A IL145802A (en) | 1999-04-09 | 2001-10-05 | Injectable compounds of naltrexone microspheres and their uses in lowering heroin and alcohol consumption |
Country Status (25)
Country | Link |
---|---|
US (1) | US6306425B1 (xx) |
EP (1) | EP1171132B1 (xx) |
JP (2) | JP4995371B2 (xx) |
KR (1) | KR100621261B1 (xx) |
CN (1) | CN1210031C (xx) |
AT (1) | ATE262906T1 (xx) |
AU (1) | AU780852B2 (xx) |
BR (1) | BR0009639A (xx) |
CA (1) | CA2369302C (xx) |
CZ (1) | CZ20013636A3 (xx) |
DE (1) | DE60009477T2 (xx) |
DK (1) | DK1171132T3 (xx) |
EA (1) | EA004734B1 (xx) |
ES (1) | ES2218147T3 (xx) |
HK (1) | HK1047245B (xx) |
HU (1) | HUP0200838A3 (xx) |
IL (2) | IL145802A0 (xx) |
MX (1) | MXPA01010185A (xx) |
NO (1) | NO328647B1 (xx) |
NZ (1) | NZ515359A (xx) |
PL (1) | PL196930B1 (xx) |
PT (1) | PT1171132E (xx) |
TR (1) | TR200102880T2 (xx) |
UA (1) | UA79921C2 (xx) |
WO (1) | WO2000061147A1 (xx) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194006B1 (en) * | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
US6610317B2 (en) | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
US7919119B2 (en) | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
AU2001223396A1 (en) * | 2000-02-01 | 2001-08-14 | Disetronic Licensing Ag | Container and device for administering a substance |
US6264987B1 (en) * | 2000-05-19 | 2001-07-24 | Alkermes Controlled Therapeutics Inc. Ii | Method for preparing microparticles having a selected polymer molecular weight |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
WO2003004030A1 (en) | 2001-07-06 | 2003-01-16 | Endo Pharmaceuticals, Inc. | Oxymorphone controlled release formulations |
ES2292775T3 (es) | 2001-07-06 | 2008-03-16 | Penwest Pharmaceuticals Co. | Formulaciones de liberacion prolongada de oximorfona. |
US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
US7462366B2 (en) | 2002-03-29 | 2008-12-09 | Boston Scientific Scimed, Inc. | Drug delivery particle |
US7157102B1 (en) | 2002-05-31 | 2007-01-02 | Biotek, Inc. | Multi-layered microcapsules and method of preparing same |
US7041320B1 (en) | 2002-05-31 | 2006-05-09 | Biotek, Inc. | High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence |
US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
US7842377B2 (en) * | 2003-08-08 | 2010-11-30 | Boston Scientific Scimed, Inc. | Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
US20040109886A1 (en) * | 2002-08-27 | 2004-06-10 | Larry Rigby | Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent |
US8012454B2 (en) | 2002-08-30 | 2011-09-06 | Boston Scientific Scimed, Inc. | Embolization |
US7883490B2 (en) | 2002-10-23 | 2011-02-08 | Boston Scientific Scimed, Inc. | Mixing and delivery of therapeutic compositions |
US7637900B2 (en) * | 2003-03-13 | 2009-12-29 | Cheryl Burgess | Methods of administering a material into a patient for dermal enhancement |
WO2004108084A2 (en) * | 2003-06-04 | 2004-12-16 | Alkermes Controlled Therapeutics, Ii | Polymorphic forms of naltrexone |
US6987111B2 (en) | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
US20050031713A1 (en) * | 2003-08-06 | 2005-02-10 | Elliot Ehrich | Methods for administering active agents to CYP3A4 sensitive patients |
US7976823B2 (en) | 2003-08-29 | 2011-07-12 | Boston Scientific Scimed, Inc. | Ferromagnetic particles and methods |
BRPI0414907A (pt) * | 2003-09-30 | 2006-11-07 | Acusphere Inc | formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas |
US7901770B2 (en) | 2003-11-04 | 2011-03-08 | Boston Scientific Scimed, Inc. | Embolic compositions |
ES2447547T3 (es) * | 2004-02-23 | 2014-03-12 | Euro-Celtique S.A. | Dispositivo de administración transdérmica de opioides con resistencia al abuso |
US7736671B2 (en) | 2004-03-02 | 2010-06-15 | Boston Scientific Scimed, Inc. | Embolization |
US20050245461A1 (en) * | 2004-03-19 | 2005-11-03 | Elliot Ehrich | Methods for treating alcoholism |
US8173176B2 (en) | 2004-03-30 | 2012-05-08 | Boston Scientific Scimed, Inc. | Embolization |
US7919499B2 (en) * | 2004-04-22 | 2011-04-05 | Alkermes, Inc. | Naltrexone long acting formulations and methods of use |
US7311861B2 (en) | 2004-06-01 | 2007-12-25 | Boston Scientific Scimed, Inc. | Embolization |
US7858183B2 (en) | 2005-03-02 | 2010-12-28 | Boston Scientific Scimed, Inc. | Particles |
US7727555B2 (en) | 2005-03-02 | 2010-06-01 | Boston Scientific Scimed, Inc. | Particles |
US7963287B2 (en) | 2005-04-28 | 2011-06-21 | Boston Scientific Scimed, Inc. | Tissue-treatment methods |
CN1872063B (zh) * | 2005-06-03 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 纳美芬或其盐的长效注射用微球或组合物及其制备方法 |
US9463426B2 (en) | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
US7947368B2 (en) | 2005-12-21 | 2011-05-24 | Boston Scientific Scimed, Inc. | Block copolymer particles |
EP1810714A1 (de) * | 2006-01-19 | 2007-07-25 | Holger Lars Hermann | Verwendung einer Kombination von Heroin und Naloxon zur Drogensubstitution |
JP2011500686A (ja) * | 2007-10-18 | 2011-01-06 | アイコ バイオテクノロジー | オピオイドと中性アンタゴニストを用いる組合せ鎮痛剤 |
US8748448B2 (en) | 2007-10-18 | 2014-06-10 | Aiko Biotechnology | Combination analgesic employing opioid agonist and neutral antagonist |
KR20100121463A (ko) | 2007-12-17 | 2010-11-17 | 라보팜 인코포레이트 | 오용 예방적 방출 제어형 제제 |
ES2509497T3 (es) | 2008-12-16 | 2014-10-17 | Paladin Labs Inc. | Formulación de liberación controlada para evitar un uso indebido |
US20100196436A1 (en) * | 2009-01-30 | 2010-08-05 | Gooberman Lance L | Implants containing disulfiram and an anti-inflammatory agent |
US8791093B2 (en) * | 2009-05-29 | 2014-07-29 | Lance L. Gooberman | Pharmaceutical delivery systems for treatment of substance abuse and other addictions |
AU2011224350B2 (en) * | 2010-03-09 | 2015-07-02 | Alkermes Pharma Ireland Limited | Alcohol resistant enteric pharmaceutical compositions |
RU2476209C1 (ru) * | 2012-02-29 | 2013-02-27 | Станислав Анатольевич Кедик | Имплантируемое лекарственное средство на основе налтрексона для лечения пациентов, зависимых от алкоголя или опиатов |
CN105722503A (zh) | 2013-08-06 | 2016-06-29 | 东国制药株式会社 | 恩替卡韦微球及包含其的非口服给药用药学组合物 |
WO2016013993A1 (en) * | 2014-07-25 | 2016-01-28 | Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. | Stable preservative free ophthalmic formulations of opioid antagonists |
HUE065740T2 (hu) | 2018-10-15 | 2024-06-28 | Chong Kun Dang Pharmaceutical Corp | Injektálható, hosszantartó hatású naltrexon mikrorészecske kompozíciók |
GR1009871B (el) * | 2019-07-30 | 2020-11-12 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει μικροσφαιριδια ναλτρεξονης και μεθοδος παρασκευης αυτου |
US20210059943A1 (en) * | 2019-09-04 | 2021-03-04 | Buffalo Pacific LLC | Systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases |
CA3208374A1 (en) * | 2021-03-09 | 2022-09-15 | Ju Hee Kim | Sustained formulation for prevention or treatment of autoimmune disease containing naltrexone and method using same |
WO2023090922A1 (ko) * | 2021-11-18 | 2023-05-25 | (주)인벤티지랩 | 날트렉손을 포함하는 서방성 주사용 조성물 및 이의 제조 방법 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3887699A (en) | 1969-03-24 | 1975-06-03 | Seymour Yolles | Biodegradable polymeric article for dispensing drugs |
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4623588A (en) | 1984-02-06 | 1986-11-18 | Biotek, Inc. | Controlled release composite core coated microparticles |
US4568559A (en) | 1984-02-06 | 1986-02-04 | Biotek, Inc. | Composite core coated microparticles and process of preparing same |
US4981696A (en) | 1986-12-22 | 1991-01-01 | E. I. Du Pont De Nemours And Company | Polylactide compositions |
DE3710175A1 (de) | 1987-02-12 | 1988-08-25 | Hoechst Ag | Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung |
FR2618674B1 (fr) | 1987-07-30 | 1990-06-15 | Ire Celltarg Sa | Microparticules comportant un polymere biodegradable controlant la liberation d'un principe actif antimalarique, compositions pharmaceutiques en comprenant et procede de preparation |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
DE3734223A1 (de) * | 1987-10-09 | 1989-04-20 | Boehringer Ingelheim Kg | Implantierbares, biologisch abbaubares wirkstofffreigabesystem |
JP2670680B2 (ja) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
US4902515A (en) | 1988-04-28 | 1990-02-20 | E. I. Dupont De Nemours And Company | Polylactide compositions |
WO1990013361A1 (en) | 1989-05-04 | 1990-11-15 | Southern Research Institute | Improved encapsulation process and products therefrom |
US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
AU2605592A (en) | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
AU7582498A (en) * | 1997-05-20 | 1998-12-11 | Yale University | Substance dependence treatment using opiate antagonists and serotonin compounds |
JPH11269094A (ja) * | 1998-01-16 | 1999-10-05 | Takeda Chem Ind Ltd | 徐放性組成物、その製造法および用途 |
-
2000
- 2000-04-07 US US09/545,064 patent/US6306425B1/en not_active Expired - Fee Related
- 2000-04-08 CZ CZ20013636A patent/CZ20013636A3/cs unknown
- 2000-04-08 ES ES00921946T patent/ES2218147T3/es not_active Expired - Lifetime
- 2000-04-08 AT AT00921946T patent/ATE262906T1/de not_active IP Right Cessation
- 2000-04-08 WO PCT/US2000/009438 patent/WO2000061147A1/en active IP Right Grant
- 2000-04-08 JP JP2000610480A patent/JP4995371B2/ja not_active Expired - Fee Related
- 2000-04-08 PL PL350548A patent/PL196930B1/pl unknown
- 2000-04-08 DK DK00921946T patent/DK1171132T3/da active
- 2000-04-08 CA CA002369302A patent/CA2369302C/en not_active Expired - Fee Related
- 2000-04-08 DE DE60009477T patent/DE60009477T2/de not_active Expired - Lifetime
- 2000-04-08 PT PT00921946T patent/PT1171132E/pt unknown
- 2000-04-08 HU HU0200838A patent/HUP0200838A3/hu unknown
- 2000-04-08 EA EA200101062A patent/EA004734B1/ru active IP Right Revival
- 2000-04-08 AU AU42203/00A patent/AU780852B2/en not_active Ceased
- 2000-04-08 BR BR0009639-3A patent/BR0009639A/pt not_active Application Discontinuation
- 2000-04-08 EP EP00921946A patent/EP1171132B1/en not_active Expired - Lifetime
- 2000-04-08 TR TR2001/02880T patent/TR200102880T2/xx unknown
- 2000-04-08 NZ NZ515359A patent/NZ515359A/xx unknown
- 2000-04-08 MX MXPA01010185A patent/MXPA01010185A/es active IP Right Grant
- 2000-04-08 IL IL14580200A patent/IL145802A0/xx active IP Right Grant
- 2000-04-08 CN CNB008085684A patent/CN1210031C/zh not_active Expired - Fee Related
- 2000-04-08 KR KR1020017012866A patent/KR100621261B1/ko not_active IP Right Cessation
- 2000-08-04 UA UA2001117615A patent/UA79921C2/uk unknown
-
2001
- 2001-10-05 IL IL145802A patent/IL145802A/en unknown
- 2001-10-08 NO NO20014896A patent/NO328647B1/no not_active IP Right Cessation
-
2002
- 2002-12-10 HK HK02108954.5A patent/HK1047245B/zh not_active IP Right Cessation
-
2009
- 2009-11-02 JP JP2009252183A patent/JP2010031036A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145802A0 (en) | Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol | |
HK1046858A1 (en) | Injectable buprenorphine microparticle compositions and their use in reducing consumption of heroin and alcohol. | |
AU2001263996A1 (en) | Prolonged release microspheres for injection delivery and preparation method | |
AU1038699A (en) | Automatic injector with needle retraction after injection | |
WO1997030731A3 (en) | Method of preparing polynucleotide-carrier complexes for delivery to cells | |
WO2001037889A3 (de) | Spritzbares knochenersatzmaterial | |
ZA921875B (en) | New esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions | |
EP0787501A3 (en) | Injector, injection needle, and injection needle disposal container | |
EP1458870A4 (en) | COMPOSITIONS AND METHODS USING ARNS, AMPHIPATHIC COMPOUNDS AND POLYCATIONS | |
AU2001269688A1 (en) | Combination containing an antifolate and methylmalonic acid lowering agent | |
WO2001026638A3 (en) | The use of baclofen in the treatment of alcoholism | |
EP1555023A3 (en) | Injectable buprenorphine microparticle compositions and their use | |
GB2364306B (en) | Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and method of preparation thereof | |
AU5971900A (en) | Hydroxyl group-containing copolymers and their use for producing fuel oils with improved lubricity | |
GB0115798D0 (en) | Organic anti-reflective coating polymer, anti-reflective coating composition and methods of preparation thereof | |
EP1296053B8 (de) | Verfahren zum direkten Einspritzen von Kraftstoff in Form von zwei Einspritzungen mit unterschiedlichen Einspritzwinkeln und eine Steuereinrichtung zum Einspritzen | |
CN2308600Y (zh) | 多功能火柴 | |
OELTGEN | Characterization and utilization of opiate-like hibernation factors(Report, 15 Jul. 1992- 15 Dec. 1993) | |
KR920703152A (ko) | 비타민-미네랄을 이용한 치료방법 및 그 조성물 | |
AU2001237117A1 (en) | Combined fuel injection and ignition means | |
UA40215A (uk) | Спосіб лікування дітей, хворих на пневмонію |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted |